Last reviewed · How we verify
NCT06324409
ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening
NA trial testing Reminder telephone call in Cancer Colorectal in 400 participants. Completed in 30 March 2025.
31 December 2024
Quick facts
| Lead sponsor | Norwegian Institute of Public Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 400 |
| Start date | 15 May 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 30 March 2025 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Reminder telephone call
Conditions studied
- Cancer Colorectal — all drugs for Cancer Colorectal →
Sponsor
Norwegian Institute of Public Health
Who can join
Eligibility, any sex, with Cancer Colorectal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized trial is to test the effect of a reminder telephone call in the official native language in the country where the invitee is born, in addition to the reminder letter in Norwegian on participation in the National Colorectal Cancer Screening Program in Pakistani and Somalian immigrants, compared to the reminder letter in Norwegian only. The main question it aims to answer is: •Does a reminder telephone call in the language of origin increase participation in colorectal cancer screening in Pakistani and Somalian immigrants in Norway? Participants in this trial are individuals with Pakistan or Somalia as their country of birth invited to the National Colorectal Cancer Screening Program, who have not participated by mailing a faecal sample to the screening laboratory. In the intervention group, the participants will be called in the official language in their country of origin, to inform about colorectal cancer screening, in addition to the reminder letter in Norwegian language sent to all non-participants. Participants in the comparison group will only be sent the reminder letter in Norwegian language. The researchers will compare differences in the participation rate in the National Colorectal Cancer Screening Program between the intervention and comparison groups.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of reminder phone calls in the language of origin on colorectal cancer screening participation among immigrants in Norway: a randomised controlled trial.
Iqbal N, Bhargava S, Hofvind S, Farah KS, et al · · 2026 · PMID 41868191 · DOI 10.1016/j.lanepe.2026.101648
Verify or expand the search:
- PubMed search for NCT06324409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer Colorectal
Currently open trials in the same condition.
- NCT07091032 — Building Connections · NA · recruiting
- NCT05585866 — Propofol and Sevoflurane Anesthesia in Colorectal Cancer Surgery: Incidence of Acute Kidney Injury · active not recruiting
- NCT04258813 — Onco-primary Care Networking to Support TEAM-based Care · NA · active not recruiting
- NCT04592003 — French Colorectal ESD Cohort in Experts Centers · recruiting
Other Norwegian Institute of Public Health trials
Trials by the same sponsor.
- NCT07442318 — Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia · NA · not yet recruiting
- NCT07135115 — Targeting Lifestyle to Improve Colorectal Cancer Screening · NA · not yet recruiting
- NCT07355569 — The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway · NA · completed
- NCT06374316 — Air Purifiers in Classrooms for Infection Control - a Pilot Study · NA · unknown
- NCT06442332 — Long-term Consequences of Cyclist Injuries · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06324409 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Norwegian Institute of Public Health
- Last refreshed: 15 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06324409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing